Clinical

Dataset Information

0

FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation


ABSTRACT: Single-arm, multi-centre phase II study The primary objective is to evaluate the time to failure of the strategy.

DISEASE(S): Adenocarcinoma,Metastatic Colorectal Cancer

PROVIDER: 2277501 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| S-EPMC6347513 | biostudies-literature
2024-02-16 | PXD044615 | Pride
2024-02-16 | PXD044749 | Pride
2024-02-16 | PXD044800 | Pride
| S-EPMC4801867 | biostudies-literature
| PRJEB38042 | ENA
| S-EPMC5655479 | biostudies-literature
| S-EPMC7408439 | biostudies-literature